TES serves as a tumor suppressor in several cancers, such as gastric cancer and breast cancer, and overexpression of TES reduces the oncogenicity and metastasis of tumor cells (Okolicsanyi et al., 2014; Xue et al., 2019). This evidence concerns the gene TES and breast carcinoma.